Autolus Therapeutics plc (AUTL)
NASDAQ: AUTL · Real-Time Price · USD
2.240
-0.050 (-2.18%)
At close: Sep 4, 2026, 4:00 PM EDT
2.247
+0.007 (0.32%)
After-hours: Sep 4, 2026, 7:39 PM EDT

Autolus Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
5965306251,120329378
Market Cap Growth
55.59%-15.31%-44.17%240.67%-13.12%-19.06%
Enterprise Value
7624872691,057233227
Last Close Price
2.241.992.356.441.905.19

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
5.087.0361.80659.6951.70162.43
PB Ratio
7.972.971.4610.051.101.21
P/TBV Ratio
10.593.351.5110.051.101.21

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
6.496.4726.63622.4836.6997.51

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
4.921.920.702.010.500.22
Net Debt / Equity Ratio
2.220.23-0.68-0.14-0.78-0.77
Net Debt / EBITDA Ratio
-0.70-0.161.250.091.711.84
Net Debt / FCF Ratio
-0.71-0.131.270.101.891.91
Asset Turnover
0.190.110.020.000.010.01
Inventory Turnover
7.1511.11----
Quick Ratio
4.065.1310.485.908.8711.79
Current Ratio
4.895.9410.886.159.1812.15
Return on Equity (ROE)
-133.00%-94.98%-81.91%-101.61%-48.64%-54.30%
Return on Assets (ROA)
-25.44%-24.62%-26.01%-25.35%-19.94%-25.07%
Return on Capital Employed (ROCE)
-58.20%-52.40%-33.40%-53.10%-32.20%-37.20%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-46.99%-54.29%-35.28%-18.60%-45.27%-37.55%
FCF Yield
-39.04%-57.14%-36.51%-13.98%-37.45%-33.48%
Buyback Yield / Dilution
-2.10%-4.30%-46.69%-83.11%-31.78%-39.81%
SEC Filings: 10-K · 10-Q